Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing

Nucleic Acids Research

Volumn 44, Issue 11, 2016, Pages

  Stahlberg, Anders ^a,b   Krzyzanowski, Paul M ^c   Jackson, Jennifer B ^a   Egyud, Matthew ^a   Stein, Lincoln ^c   Godfrey, Tony E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BIOPSY; CELL CLONE; CELL FREE SYSTEM; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA BARCODING; DNA HAIRPIN; DNA LIBRARY; DNA STRUCTURE; GENE MUTATION; HUMAN; LIQUID BIOPSY; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; CELL LINE; CHEMISTRY; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENE LIBRARY; GENETICS; HIGH THROUGHPUT SEQUENCING; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; REPRODUCIBILITY;

PRIMER DNA;

BIOPSY; CELL LINE; DNA BARCODING, TAXONOMIC; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; GENE LIBRARY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 84976444287     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw224     Document Type: Article

References (26)

1. ten Bosch J.R, and Grody W.W. (2008). Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. J. Mol. Diagn, 10, 484-492.
2. Fox E.J. Reid-Bayliss K.S, Emond M.J, and Loeb L.A. (2014). Accuracy of next generation sequencing platforms. Next Gener. Seq. Appl, 1.
3. Lo Y.M, and Chiu R.W. (2012). Genomic analysis of fetal nucleic acids in maternal blood. Annu. Rev. Genomics Hum. Genet, 13, 285-306.
4. Diaz L.A. Jr and Bardelli A. (2014). Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol, 32, 579-586.
5. New M.I, Tong Y.K, Yuen T, Jiang P, Pina C, Chan K.C, Khattab A, Liao G.J, Yau M, Kim S.M, et al. (2014). Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin. Endocrinol.Metab, 99, E1022-E1030.
6. Chitty L.S, and Lo Y.M. (2015). Noninvasive prenatal screening for genetic diseases using massively parallel sequencing of maternal plasma DNA. Cold Spring Harb. Perspect. Med, 5.
7. Tsui N.B, Kadir R.A, Chan K.C, Chi C, Mellars G, Tuddenham E.G, Leung T.Y, Lau T.K, Chiu R.W, and Lo Y.M. (2011). Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood, 117, 3684-3691.
8. Murtaza M, Dawson S.J, Tsui D.W, Gale D, Forshew T, Piskorz A.M, Parkinson C, Chin S.F, Kingsbury Z, Wong A.S, et al. (2013). Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature, 497, 108-112.
9. Tie J, Kinde I, Wang Y, Wong H.L, Roebert J, Christie M, Tacey M, Wong R, Singh M, Karapetis C.S, et al. (2015). Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann. Oncol, 8, 1715-1722.
10. Hoque M.O, Lee J, Begum S, Yamashita K, Engles J.M, Schoenberg M, Westra W.H, and Sidransky D. (2003). High-Throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res, 63, 5723-5726.
11. Thunnissen F.B. (2003). Sputum examination for early detection of lung cancer. J. Clin. Pathol, 56, 805-810.
12. Diehl F, Schmidt K, Durkee K.H, Moore K.J, Goodman S.N, Shuber A.P, Kinzler K.W, and Vogelstein B. (2008). Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology, 135, 489-498.
13. Li J, Milbury C.A, Li C, and Makrigiorgos G.M. (2009). Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma. Hum. Mutat, 30, 1583-1590.
14. Milbury C.A, Correll M, Quackenbush J, Rubio R, and Makrigiorgos G.M. (2012). COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing. Clin. Chem, 58, 580-589.
15. Vogelstein B, and Kinzler K.W. (1999). Digital PCR. Proc. Natl. Acad. Sci. U.S.A, 96, 9236-9241.
16. Barrett A.N, McDonnell T.C, Chan K.C, and Chitty L.S. (2012). Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin. Chem, 58, 1026-1032.
17. Taly V, Pekin D, Benhaim L, Kotsopoulos S.K, Le Corre D, Li X, Atochin I, Link D.R, Griffiths A.D, Pallier K, et al. (2013). Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin. Chem, 59, 1722-1731.
18. Forshew T, Murtaza M, Parkinson C, Gale D, Tsui D.W, Kaper F, Dawson S.J, Piskorz A.M, Jimenez-Linan M, Bentley D, et al. (2012). Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med, 4, 136ra168.
19. Schmitt M.W, Kennedy S.R, Salk J.J, Fox E.J, Hiatt J.B, and Loeb L.A. (2012). Detection of ultra-rare mutations by next-generation sequencing. Proc. Natl. Acad. Sci. U.S.A, 109, 14508-14513.
20. Kinde I, Wu J, Papadopoulos N, Kinzler K.W, and Vogelstein B. (2011). Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl. Acad. Sci. U.S.A, 108, 9530-9535.
21. Peng Q, Vijaya Satya R, Lewis M, Randad P, and Wang Y. (2015). Reducing amplification artifacts in high multiplex amplicon sequencing by using molecular barcodes. BMC Genomics, 16, 589.
22. Narayan A, Carriero N.J, Gettinger S.N, Kluytenaar J, Kozak K.R, Yock T.I, Muscato N.E, Ugarelli P, Decker R.H, and Patel A.A. (2012). Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res, 72, 3492-3498.
23. Bettegowda C, Sausen M, Leary R.J, Kinde I, Wang Y, Agrawal N, Bartlett B.R, Wang H, Luber B, Alani R.M, et al. (2014). Detection of circulating tumor DNA in early- And late-stage human malignancies. Sci. Transl. Med, 6, 224ra224.
24. Andersson D, Akrap N, Svec D, Godfrey T.E, Kubista M, Landberg G, and Stahlberg A. (2015). Properties of targeted preamplification in DNA and cDNA quantification. Expert Rev. Mol. Diagn, 15, 1085-1100.
25. Brownie J, Shawcross S, Theaker J, Whitcombe D, Ferrie R, Newton C, and Little S. (1997). The elimination of primer-dimer accumulation in PCR. Nucleic Acids Res, 25, 3235-3241.
26. Tyagi S, and Kramer F.R. (1996). Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol, 14, 303-308.